Even as the need for proper legislation to control gun sales is vehemently debated on various forums, one more firm has joined the group of businesses that adopted measures to curb firearm sale. In a noble gesture, sporting goods retailer Dick’s Sporting Goods has decided to stop selling assault rifles to persons aged below 21 years, with immediate effect.
Earlier, leading retailers including Walmart had vowed to put restrictions on gun sale, joining the nation-wide chorus for regulation in the wake of the Florida school shooting in which 17 persons lost their lives.
Dick’s will also keep away from selling high-capacity magazines. Though the age limit has been set at 21 years, those aged 18 and above will be eligible to buy lighter firearms like semiautomatic rifles.
Meanwhile, Walmart went one step ahead and declared it would not sell even items like toy guns that resemble assault rifles, sending a strong message to the gun supporters. Walmart had stopped dealing in high-end firearms, including AR-15-style guns, about three years ago.
Speaking at an interview, Dick’s CEO Edward Stack said, “When we saw what happened in Parkland, we were so disturbed and upset. We love these kids and their rallying cry, ‘Enough is enough.’ It got to us.”
The strong response from corporate America came as a blow to the National Rifle Association, which has raised objections to the Congress’ initiatives to bring in regulation, following intervention by President Trump.
Though the age limit has been set at 21 years, those aged 18 and above will be eligible to buy lighter firearms
The other companies who have severed their association with the National Rifles Association include MetLife Insurance, Hertz Car Rental, and Delta Air Lines.
Most of those who demand effective laws against licensing of firearms are of the view that the firearms-related crimes occurring in America are unique to the country. They blame the alleged inaction on the part of changing governments for the recurring shooting incidents.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on